Re: Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?D. Deniffel, E. Salinas, M. Ientilucci, A. J. Evans, N. Fleshner, S. Ghai, R. Hamilton, A. Roberts, A. Toi, T. van der Kwast, A. Zlotta, A. Finelli, M. A. Haider and N. Perlis J Urol 2020; doi: 10.1097/JU.0000000000001157

Vasilis Stavrinides; Francesco Giganti; Shonit Punwani; Clare Allen; Alex Kirkham; Alex Freeman; Rhys Ball; Aiman Haider; Hayley Whitaker; Clement Orczyk; Mark Emberton; Caroline M Moore

doi:10.1097/JU.0000000000001295

Re: Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?D. Deniffel, E. Salinas, M. Ientilucci, A. J. Evans, N. Fleshner, S. Ghai, R. Hamilton, A. Roberts, A. Toi, T. van der Kwast, A. Zlotta, A. Finelli, M. A. Haider and N. Perlis J Urol 2020; doi: 10.1097/JU.0000000000001157

J Urol. 2020 Nov;204(5):1065-1066. doi: 10.1097/JU.0000000000001295. Epub 2020 Jul 23.

Authors

Vasilis Stavrinides^{1

2

3}, Francesco Giganti^{1

2

3}, Shonit Punwani^{1

2

3}, Clare Allen^{1

2

3}, Alex Kirkham^{1

2

3}, Alex Freeman^{1

2

3}, Rhys Ball^{1

2

3}, Aiman Haider^{1

2

3}, Hayley Whitaker^{1

2

3}, Clement Orczyk^{1

2

3}, Mark Emberton^{1

2

3}, Caroline M Moore^{1

2

3}

Affiliations

¹ Division of Surgery and Interventional Science, University College London, London, United Kingdom.
² Department of Urology, Department of Radiology, Department of Pathology, University College London Hospital NHS Foundation Trust, London, United Kingdom.
³ The Alan Turing Institute, London, United Kingdom.

PMID: 32698715
DOI: 10.1097/JU.0000000000001295

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Male
Multiparametric Magnetic Resonance Imaging*
Neoplasm Grading
Prostatic Neoplasms* / diagnostic imaging

Grants and funding

MR/S005897/1/MRC_/Medical Research Council/United Kingdom